Comparison of the decomposition behaviors of hardwood and softwood in supercritical methanol

The chemical conversion of Japanese beech (Fagus crenata Blume) and Japanese cedar (Cryptomeria japonica D. Don) woods in supercritical methanol was studied using the supercritical fluid biomass conversion system with a batch-type reaction vessel. Under conditions of 270°C/27 MPa, beech wood was decomposed and liquefied to a greater extent than cedar wood, and the difference observed was thought to originate mainly from differences in the intrinsic properties of the lignin structures of hardwood and softwood. However, such a difference was not observed at 350°C/43 MPa, and more than 90% of both beech and cedar woods were effectively decomposed and liquefied after 30 min of treatment. This result indicates that the supercritical methanol treatment is expected to be an efficient tool for converting the woody biomass to lower-molecular-weight products, such as liquid fuels and useful chemicals

Characterization of lignin-derived products from various lignocellulosics as treated by semi-flow hot-compressed water

To elucidate the decomposition behaviors of lignin from different taxonomic groups, five different lignocellulosics were treated with hot-compressed water (230 °C/10 MPa/15 min) to fractionate lignins into water-soluble portions, precipitates, and insoluble residues. The lignin-derived products in each fraction were characterized and compared. The delignification of monocotyledons [nipa palm (Nypa fruticans) frond, rice (Oryza sativa) straw, and corn (Zea mays) cob] was more extensive than that achieved for Japanese cedar (Cryptomeria japonica, gymnosperm) and Japanese beech (Fagus crenata, dicotyledon angiosperm). The water-soluble portions contained lignin monomers like coniferyl alcohol and phenolic acids, while the precipitates contained higher molecular weight lignin with high content of ether-type linkages. Lignin in the insoluble residues was rich in condensed-type structures. In all five lignocellulosics, ether-type linkages were preferentially cleaved, while condensed-type lignin showed resistance to hot-compressed water. In the monocotyledons, lignin–carbohydrate complexes were cleaved and gave lignins that had higher molecular weights than those eluted from the woods. These differences would facilitate the delignification in monocotyledons. Such information provides useful information for efficient utilization of various lignocellulosics

Characterization of three tissue fractions in corn (Zea mays) cob

Corn (Zea mays) cob is composed of three tissue fractions, chaff, woody ring, and pith, with dry weight percentages of 21.1%, 77.5%, and 1.4%, respectively. In this study, the cell wall components in these tissue fractions were characterized to examine their tissue morphology. The chemical compositions in the three fractions were relatively similar, and hemicellulose was the main component. Through sugar composition analysis, hemicellulose was mainly composed of xylan in all fractions, whereas the proportion of arabinose and galactose was different in the woody ring. From the alkaline nitrobenzene oxidation analysis, lignin in all fractions was composed of guaiacyl, syringyl, and p-hydroxyphenyl lignins, whereas their ratios varied in the three fractions. Furthermore, the amounts of cinnamic acids such as ferulic and p-coumaric acids, which are associated with corn lignin, were also different among the three fractions. With respect to the tissue morphology, the component cells in the three fractions were totally different each other. Furthermore, from the ultraviolet microspectrophotometry of each morphological region in the three tissue fractions, lignin concentration and distribution of cinnamic acids were different from one morphological region to another. The differences in chemical composition and lignin structures influence the decomposition behaviors in various treatments; thus, this information provides a clue to promote efficient utilization of corn cob into value-added chemicals

TiO2-supported Ni-Sn as an effective hydrogenation catalyst for aqueous acetic acid to ethanol

Various Ni and Ni-Sn catalysts supported on TiO2 were prepared and the catalytic activities were evaluated for ethanol formation from aqueous acetic acid. Although catalytic activities of the Ni/TiO2 catalysts were limited, the addition of Sn improved the activity dramatically, and the optimum Ni/Sn ratio was approximately 1:1 (w/w). SnO2, the precursor of Sn, could not be reduced into metal Sn in pure form but did reduce into Ni-Sn alloys in the presence of NiO, the precursor of Ni. Analyses with XRD and SEM-EDS revealed that the Ni-Sn alloys were homogeneously dispersed on the TiO2 surface. Furthermore, IR analysis indicated that the Ti atoms in the catalyst act as a Lewis acid, which coordinates to the oxygen atoms of acetic acid, enhancing the attack of hydrogens activated on neighboring Ni-Sn alloys. Based on these results, Ni-Sn/TiO2 is proposed as an effective hydrogenation catalyst for converting aqueous acetic acid into ethanol

Differential scanning calorimetric study of solidification behavior of monoacylglycerols to investigate the cold-flow properties of biodiesel

Monoacylglycerols (MAG) are impurities present in biodiesel as a result of incomplete reactions. MAG often solidify in biodiesel even at room temperature because of their high melting points. This worsens the cold‐flow properties such as the cloud point and pour point. We hypothesized that several types of MAG solidify simultaneously; therefore, we performed differential scanning calorimetry of binary mixtures of MAG to elucidate their interactions during solidification. Three thermodynamic formulas were then applied to the experimental results: (1) non‐solid‐solution, (2) solid‐solution, and (3) compound formation models. Binary mixtures of MAG showed complicated liquidus curves with multiple upward convex shapes, with which only the compound formation model fitted well. This model was applied to multicomponent mixtures that consisted of MAG and fatty acid methyl esters (FAME) as surrogate biodiesel fuels. We confirmed that the model still worked well. The results show that the compound formation model has good potential for predicting the cold‐flow properties of biodiesel

Predicting Solid–Liquid Equilibrium of Fatty Acid Methyl Ester and Monoglyceride Mixtures as Biodiesel Model Fuels

An erratum to this article is available at https://doi.org/10.1007/s11746‐017‐3029‐4.Fatty acid methyl esters from plant oils are the main component of biodiesel and used as a substitute for petroleum diesel. Biodiesel generally contains a small amount of monoglycerides as intermediate compounds, which have high melting points and often solidify and clog fuel filters. The prediction of the cold‐flow property of biodiesel is of great importance for practical application. In this study, a thermodynamic study was conducted for mixtures of monoglycerides and fatty acid methyl esters. Temperatures of the solid–liquid equilibrium for the mixtures were measured by differential scanning calorimetry and visual observation, while the theoretical values were calculated using the modified Universal Quasi‐chemical Functional‐group Activity Coefficients (UNIFAC) model (Dortmund). The theoretical and experimental results were in good agreement, especially for binary mixtures of monoglycerides and methyl esters. The importance of monoglycerides on the cold‐flow properties of biodiesel was determined, and the effects could be well described by the modified UNIFAC model (Dortmund)

Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration

<p>Abstract</p> <p>Background</p> <p>Viral reservoir size refers to cellular human immunodeficiency virus-1 (HIV-1) DNA levels in CD4⁺T lymphocytes of peripheral blood obtained from patients with plasma HIV-1-RNA levels (viral load, VL) maintained below the detection limit by antiretroviral therapy (ART). We measured HIV-1 DNA levels in CD4⁺lymphocytes in such patients to investigate their clinical significance.</p> <p>Methods</p> <p>CD4⁺T lymphocytes were isolated from the peripheral blood of 61 patients with a VL maintained at less than 50 copies/ml for at least 4 months by ART and total DNA was purified. HIV-1 DNA was quantified by nested PCR to calculate the copy number per 1 million CD4⁺lymphocytes (relative amount) and the copy number in 1 ml of blood (absolute amount). For statistical analysis, the Spearman rank or Wilcoxon signed-rank test was used, with a significance level of 5%.</p> <p>Results</p> <p>CD4 cell counts at the time of sampling negatively correlated with the relative amount of HIV-1 DNA (median = 33 copies/million CD4⁺lymphocytes; interquartile range [IQR] = 7-123 copies/million CD4⁺lymphocytes), but were not correlated with the absolute amounts (median = 17 copies/ml; IQR = 5-67 copies/ml). Both absolute and relative amounts of HIV-1 DNA were significantly lower in six patients in whom ART was initiated before positive seroconversion than in 55 patients in whom ART was initiated in the chronic phase, as shown by Western blotting. CD4 cell counts before ART introduction were also negatively correlated with both the relative and absolute amounts of HIV-1 DNA. Only the relative amounts of HIV-1 DNA negatively correlated with the duration of VL maintenance below the detection limit, while the absolute amounts were not significantly correlated with this period.</p> <p>Conclusions</p> <p>The amounts of cellular HIV-1 DNA in patients with VLs maintained below the detection limit by the introduction of ART correlated with the timing of ART initiation but not with the duration of ART. In addition, CD4⁺T lymphocytes, which were newly generated by ART, diluted latently infected cells, indicating that measurements of the relative amounts of cellular HIV-1 DNA might be underestimated.</p

Management of Hepatocellular Carcinoma in Japan : JSH Consensus Statements and Recommendations 2021 Update

The Clinical Practice Manual for Hepatocellular Carcinoma was published based on evidence confirmed by the Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma along with consensus opinion among a Japan Society of Hepatology (JSH) expert panel on hepatocellular carcinoma (HCC). Since the JSH Clinical Practice Guidelines are based on original articles with extremely high levels of evidence, expert opinions on HCC management in clinical practice or consensus on newly developed treatments are not included. However, the practice manual incorporates the literature based on clinical data, expert opinion, and real-world clinical practice currently conducted in Japan to facilitate its use by clinicians. Alongside each revision of the JSH Guidelines, we issued an update to the manual, with the first edition of the manual published in 2007, the second edition in 2010, the third edition in 2015, and the fourth edition in 2020, which includes the 2017 edition of the JSH Guideline. This article is an excerpt from the fourth edition of the HCC Clinical Practice Manual focusing on pathology, diagnosis, and treatment of HCC. It is designed as a practical manual different from the latest version of the JSH Clinical Practice Guidelines. This practice manual was written by an expert panel from the JSH, with emphasis on the consensus statements and recommendations for the management of HCC proposed by the JSH expert panel. In this article, we included newly developed clinical practices that are relatively common among Japanese experts in this field, although all of their statements are not associated with a high level of evidence, but these practices are likely to be incorporated into guidelines in the future. To write this article, coauthors from different institutions drafted the content and then critically reviewed each other’s work. The revised content was then critically reviewed by the Board of Directors and the Planning and Public Relations Committee of JSH before publication to confirm the consensus statements and recommendations. The consensus statements and recommendations presented in this report represent measures actually being conducted at the highest-level HCC treatment centers in Japan. We hope this article provides insight into the actual situation of HCC practice in Japan, thereby affecting the global practice pattern in the management of HCC

A Functional SNP in BNC2 Is Associated with Adolescent Idiopathic Scoliosis

Adolescent idiopathic scoliosis (AIS) is the most common spinal deformity. We previously conducted a genome-wide association study (GWAS) and detected two loci associated with AIS. To identify additional loci, we extended our GWAS by increasing the number of cohorts (2,109 affected subjects and 11,140 control subjects in total) and conducting a whole-genome imputation. Through the extended GWAS and replication studies using independent Japanese and Chinese populations, we identified a susceptibility locus on chromosome 9p22.2 (p = 2.46 × 10−13; odds ratio = 1.21). The most significantly associated SNPs were in intron 3 of BNC2, which encodes a zinc finger transcription factor, basonuclin-2. Expression quantitative trait loci data suggested that the associated SNPs have the potential to regulate the BNC2 transcriptional activity and that the susceptibility alleles increase BNC2 expression. We identified a functional SNP, rs10738445 in BNC2, whose susceptibility allele showed both higher binding to a transcription factor, YY1 (yin and yang 1), and higher BNC2 enhancer activity than the non-susceptibility allele. BNC2 overexpression produced body curvature in developing zebrafish in a gene-dosage-dependent manner. Our results suggest that increased BNC2 expression is implicated in the etiology of AIS

An international survey of physicians regarding clinical trials: a comparison between Kyoto University Hospital and Seoul National University Hospital

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Abstract Background International clinical trials are now rapidly expanding into Asia. However, the proportion of global trials is higher in South Korea compared to Japan despite implementation of similar governmental support in both countries. The difference in clinical trial environment might influence the respective physicians attitudes and experience towards clinical trials. Therefore, we designed a questionnaire to explore how physicians conceive the issues surrounding clinical trials in both countries. Methods A questionnaire survey was conducted at Kyoto University Hospital (KUHP) and Seoul National University Hospital (SNUH) in 2008. The questionnaire consisted of 15 questions and 2 open-ended questions on broad key issues relating to clinical trials. Results The number of responders was 301 at KUHP and 398 at SNUH. Doctors with trial experience were 196 at KUHP and 150 at SNUH. Among them, 12% (24/196) at KUHP and 41% (61/150) at SUNH had global trial experience. Most respondents at both institutions viewed clinical trials favorably and thought that conducting clinical trials contributed to medical advances, which would ultimately lead to new and better treatments. The main reason raised as a hindrance to conducting clinical trials was the lack of personnel support and time. Doctors at both university hospitals thought that more clinical research coordinators were required to conduct clinical trials more efficiently. KUHP doctors were driven mainly by pure academic interest or for their desire to find new treatments, while obtaining credits for board certification and co-authorship on manuscripts also served as motivation factors for doctors at SNUH. Conclusions Our results revealed that there might be two different approaches to increase clinical trial activity. One is a social level approach to establish clinical trial infrastructure providing sufficient clinical research professionals. The other is an individual level approach that would provide incentives to encourage doctors to participate in and conduct clinical trials